Gilead/ News/ R&D Gilead to take selonsertib into phase 3 in NASH Richard Staines Allergan, diabetic kidney disease, Gilead, Intercept, NASH, non-alcoholic steatohepatitis, pulmonary arterial hypertension, Shire 0 Comment But drug flops in two other indications. Share X Gilead to take selonsertib into phase 3 in NASH https://pharmaphorum.com/news/gilead-take-selonsertib-phase-3-nash/